Targacept (TRGT) and AstraZeneca (AZN) announce their experimental depression pill failed to...


Targacept (TRGT) and AstraZeneca (AZN) announce their experimental depression pill failed to show any improvement for patients in a clinical trial. The firms are studying TC-5214 as a potential additional therapy for patients no longer responding to other antidepressants. Premarket: TRGT -50.3%, AZN -3.3%.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs